A new index for distinguishing hypereosinophilic syndrome and antineutrophil cytoplasmic antibody-negative eosinophilic granulomatosis with polyangiitis

被引:0
|
作者
Ahn, Sung Soo [1 ]
Yoo, Juyoung [1 ]
Park, Yong-Beom [1 ,2 ]
Park, Jung-Won [3 ,4 ]
Lee, Jae-Hyun [3 ,4 ,6 ]
Lee, Sang-Won [1 ,2 ,5 ]
机构
[1] Yonsei Univ, Coll Med, Dept Internal Med, Div Rheumatol, Seoul, South Korea
[2] Yonsei Univ, Coll Med, Inst Immunol & Immunol Dis, Seoul, South Korea
[3] Yonsei Univ, Coll Med, Dept Internal Med, Div Allergy, Seoul, South Korea
[4] Yonsei Univ, Coll Med, Inst Allergy, Seoul, South Korea
[5] Yonsei Univ, Coll Med, Inst Immunol & Immunol Dis, Div Rheumatol,Dept Internal Med, 50-1 Yonsei Ro, Seoul 03722, South Korea
[6] Yonsei Univ, Inst Allergy, Dept Internal Med, Div Allergy,Coll Med, 50-1 Yonsei Ro, Seoul 03722, South Korea
关键词
hypereosinophilic syndrome; eosinophilic granulomatosis with polyangiitis; predictor; differentiation; index; CHURG-STRAUSS-SYNDROME; VASCULITIDES; ASTHMA;
D O I
10.12932/ap-080420-0805
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Background: It is difficult to differentiate between hypereosinophilic syndrome (HES) and antineutrophil cytoplasmic antibody (ANCA)-negative eosinophilic granulomatosis with polyangiitis (EGPA).Objective: We compared laboratory data at diagnosis between Korean patients with HES and ANCA-negative EGPA and investigated independent laboratory predictors suggesting HES.Methods: We reviewed the medical records of 41 HES patients and 16 ANCA-negative EGPA patients. The cut-offs were extrapolated by the receiver operator characteristic (ROC) curve. The odds ratio (OR) and relative risk (RR) were assessed using the multivariable logistic regression analysis and the chi-square test, respectively. We developed a new equation by assigning a weight to each variable according to the slopes (B) and expressed a decimal as the nearest integer.Results: HES patients had a higher median WBC and eosinophil counts than ANCA-negative EGPA patients. The cutoffs of WBC and eosinophil counts for HES were set at 9,900.0/mm(3) and 2,400.0/mm(3). In the multivariable analysis, WBC count >= 9,900.0/mm(3) (B 1.763) and eosinophil count >= 2,400.0/mm(3) (B 1.515) were significantly associated with HES. An equation was as follows: HES-suggesting laboratory index (HSLI) = 2 x (WBC count >= 9,900.0/mm(3) (1 = No or 2 = Yes)) + 1.5 x (eosinophil count >= 2,400.0/mm(3) (1 = No or 2 = Yes)). The cut-off of HSLI for HES was 4.25. Patients with HSLI >= 4.25 exhibited a significantly high RR (51.429) for HES, compared to those without.Conclusions: In conclusion, the cut-off of HSLI derived from WBC and eosinophil counts could be an independent predictor of HES in patients suspected of both HES and ANCA-negative EGPA.
引用
收藏
页码:244 / 252
页数:9
相关论文
共 38 条
  • [21] Anti-Neutrophil Cytoplasmic Antibody-Negative Central Nervous System Granulomatosis With Polyangiitis and Its Clinical Characteristics
    Chen, Zhihua
    Miao, Yifeng
    Wu, Hui
    Wang, Ran
    Zhou, Zhiyi
    Zhang, Shilei
    Chen, Longtian
    Qiu, Yongming
    JOURNAL OF CRANIOFACIAL SURGERY, 2018, 29 (02) : 449 - 451
  • [22] The Reclassification of Patients With Previously Diagnosed Eosinophilic Granulomatosis With Polyangiitis Based on the 2022 ACR/EULAR Criteria for Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
    Pyo, Jung Y.
    Ahn, Sung S.
    Song, Jason J.
    Park, Yong-Beom
    Lee, Sang-Won
    JOURNAL OF RHEUMATOLOGY, 2023, 50 (02) : 213 - 218
  • [23] A Changing Anti-Neutrophil Cytoplasmic Antibody Profile in a Patient With a Diagnosis of Eosinophilic Granulomatosis With Polyangiitis
    Jinno, Yusuke
    Kozu, Yutaka
    Hiranuma, Hisato
    Maruoka, Shuichiro
    Gon, Yasuhiro
    JOURNAL OF MEDICAL CASES, 2023, 14 (08) : 299 - 306
  • [24] Antineutrophil Cytoplasmic Antibodies and Organ-Specific Manifestations in Eosinophilic Granulomatosis with Polyangiitis: A Systematic Review and Meta-Analysis
    Chang, Hua-Ching
    Chou, Pai-Chien
    Lai, Chun-Yu
    Tsai, Hsiou-Hsin
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2021, 9 (01) : 445 - 452.e6
  • [25] Myeloperoxidase-Antineutrophil Cytoplasmic Antibody (ANCA)-Positive and ANCA-Negative Patients With Granulomatosis With Polyangiitis (Wegener's) Distinct Patient Subsets
    Miloslavsky, Eli M.
    Lu, Na
    Unizony, Sebastian
    Choi, Hyon K.
    Merkel, Peter A.
    Seo, Philip
    Spiera, Robert
    Langford, Carol A.
    Hoffman, Gary S.
    Kallenberg, Cees G. M.
    St Clair, E. William
    Tchao, Nadia K.
    Fervenza, Fernando
    Monach, Paul A.
    Specks, Ulrich
    Stone, John H.
    ARTHRITIS & RHEUMATOLOGY, 2016, 68 (12) : 2945 - 2952
  • [26] Hypereosinophilia with asthma and systemic (non-vasculitic) manifestations: Eosinophilic granulomatosis with polyangiitis or hypereosinophilic syndrome?
    Lefevre, Guillaume
    Ackermann, Felix
    Kahn, Jean-Emmanuel
    AUTOIMMUNITY REVIEWS, 2017, 16 (02) : 208 - 209
  • [27] Negative anti-neutrophil cytoplasmic antibodies and eosinophilic granulomatosis with polyangiitis accompanied by cough variant asthma: a case report
    Li, Yanming
    Chen, Zhengli
    Zhu, Shumin
    Bai, Fan
    Liu, Yuecai
    Gao, Lingling
    Li, Xinyuan
    Geng, Yulan
    Zhang, Guoqiang
    ANNALS OF PALLIATIVE MEDICINE, 2021, 10 (10) : 11209 - 11215
  • [28] Optimal therapy and prospects for new medicines in eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome)
    Pagnoux, Christian
    Groh, Matthieu
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2016, 12 (10) : 1059 - 1067
  • [29] Eosinophilie: hypereosinophiles Syndrom versus eosinophile Granulomatose mit PolyangiitisEosinophilia: hypereosinophilic syndrome vs. eosinophilic granulomatosis with polyangiitis
    Julia U. Holle
    Frank Moosig
    Zeitschrift für Rheumatologie, 2023, 82 (4) : 307 - 320
  • [30] Anti-neutrophil cytoplasmic antibody-positive eosinophilic granulomatosis with polyangiitis: can it cause membranous nephropathy?
    Mahmood, S. B.
    Ahmad, H.
    Wu, J.
    Haselby, D.
    LeClaire, M. M.
    Nasr, R.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2019, 48 (03) : 256 - 257